GT Biopharma (GTBP)
(Delayed Data from NSDQ)
$3.35 USD
-0.41 (-10.84%)
Updated Apr 26, 2024 03:13 PM ET
After-Market: $3.21 -0.14 (-4.04%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -2.70 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -10.81 |
Next Year | NA |
EPS (TTM) | -12.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.70 | -2.70 | -10.81 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | -2.70 | -2.70 | -10.81 | NA |
High Estimate | -2.70 | -2.70 | -10.81 | NA |
Low Estimate | -2.70 | -2.70 | -10.81 | NA |
Year ago EPS | -2.40 | -2.70 | -5.64 | -10.81 |
Year over Year Growth Est. | -12.50% | 0.00% | -91.67% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 1 | 1 | 1 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.70 | -2.70 | -10.81 | NA |
7 Days Ago | -2.70 | -2.70 | -10.81 | NA |
30 Days Ago | -2.70 | -2.70 | -10.81 | NA |
60 Days Ago | -2.70 | -2.70 | -10.81 | NA |
90 Days Ago | -2.70 | -2.70 | -10.81 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.70 | -2.70 | -10.81 | NA |
Zacks Consensus Estimate | -2.70 | -2.70 | -10.81 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -1.80 | -2.70 | -2.40 | NA |
Estimate | NA | -3.00 | -3.00 | -4.80 | NA |
Difference | NA | 1.20 | 0.30 | 2.40 | 1.30 |
Surprise | NA | 40.00% | 10.00% | 50.00% | 33.33% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more